Woodward Financial Advisors’s GSK GSK Stock Holding History

Woodward Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,696	Closed	-$201K	–	47
2022 Q2	$201K	Buy	+3,696	New	+$204K	0.19%	46

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Woodward Financial Advisors's GSK Position: Q3 2022 in Review

Woodward Financial Advisors sold out of GSK (GSK) in Q3 2022, closing a stake of 3,696 shares — an estimated $201K sold.

Woodward Financial Advisors first reported a position in GSK in Q2 2022 and held it in 1 quarter. The position peaked at $201K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Woodward Financial Advisors reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Woodward Financial Advisors sold 3,696 GSK shares in Q3 2022, an estimated $201K.
Woodward Financial Advisors first reported a position in GSK in Q2 2022 and held it in 1 quarter.
Woodward Financial Advisors's GSK position peaked at $201K in Q2 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Woodward Financial Advisors's 13F filing for Q3 2022, filed 1 Oct 2026.